BRIEF published on 12/03/2025 at 09:53, 1 day 22 hours ago Sartorius Stedim Biotech: Number of Shares and Voting Rights Share Capital Voting Rights Actions Sartorius Stedim Biotech AMF Regulations
PRESS RELEASE published on 12/03/2025 at 09:49, 1 day 22 hours ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech S.A. announced the declaration of shares and voting rights in their issued capital as of November 30, 2025 Voting Rights Shares Sartorius Stedim Biotech France Aubagne
PRESS RELEASE published on 12/03/2025 at 09:48, 1 day 22 hours ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA declares total number of shares and voting rights in the issued capital as of November 30, 2025 Voting Rights Shares Sartorius Stedim Biotech SA Regulatory Disclosure Issued Capital
BRIEF published on 11/03/2025 at 11:37, 1 month 1 day ago Sartorius Stedim Biotech Announces Share and Voting Rights Update Voting Rights Regulatory Compliance Financial Reporting Sartorius Stedim Biotech Issued Capital
PRESS RELEASE published on 11/03/2025 at 11:33, 1 month 1 day ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech S.A. in Aubagne, France, declares the number of shares and voting rights in their issued capital as of October 31, 2025 Voting Rights Shares Sartorius Stedim Biotech France Aubagne
PRESS RELEASE published on 11/03/2025 at 11:32, 1 month 1 day ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA issues declaration regarding number of shares and voting rights, as of October 31, 2025 Voting Rights Déclaration Shares Sartorius Stedim Biotech SA Issued Capital
BRIEF published on 10/16/2025 at 11:19, 1 month 19 days ago Sartorius Stedim Biotech presents robust results for 2025 Sartorius Stedim Biotech Turnover Current EBITDA 2025 Forecast 2025 Financial Results
BRIEF published on 10/16/2025 at 07:05, 1 month 20 days ago Sartorius Stedim Biotech Reports Significant Growth in 2025 Sales Growth Sartorius Stedim Biotech Biopharmaceutical Industry EBITDA Increase 2025 Financial Outlook
PRESS RELEASE published on 10/16/2025 at 07:00, 1 month 20 days ago Sartorius Stedim Biotech publishes unaudited results for the first nine months of 2025 Sartorius Stedim Biotech reports strong financial performance in the first nine months of 2025, with revenue growth, increased EBITDA, and enhanced product offerings EBITDA Revenue Growth Financial Performance Sartorius Stedim Biotech Product Offerings
BRIEF published on 10/06/2025 at 16:40, 1 month 29 days ago Sartorius Stedim Biotech Updates on Share and Voting Structures Sartorius Stedim Biotech AMF Regulations Issued Capital Investor Disclosure Shares And Voting
Published on 12/05/2025 at 02:35, 5 hours 28 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 7 hours 3 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 58 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 9 hours 3 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 1 hour 2 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 4 hours 32 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 8 hours 12 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 11 hours 37 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 48 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:00, 14 hours 3 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 14 hours 18 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 14 hours 19 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 1 hour ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 14 hours ago Declaration of voting rights at the end of November 2025
